Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Current Protocols in Cytometry
|
November 13, 2018
Flow Cytometry Method Validation Protocols
Nithianandan Selliah, Steven Eck, Cherie Green, et al.
Cellular Immunology
|
May 5, 2009
Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD)
Tinghua Cao, Allis Soto, Wei Zhou, et al.
Current Protocols
|
January 25, 2024
Correction: Flow Cytometry Method Validation Protocols
Nithianandan Selliah, Veronica Nash, Steven Eck, et al.
Current Protocols
|
August 22, 2023
Flow Cytometry Method Validation Protocols
Nithianandan Selliah, Veronica Nash, Steven Eck, et al.
Cytometry. Part B, Clinical Cytometry
|
September 17, 2020
High-sensitivity flow cytometric assays: Considerations for design control and analytical validation for identification of Rare events
Ulrike Sommer, Steven Eck, Laura Marszalek, et al.
Plos One
|
May 24, 2024
A comparative study of blood cell count in four automated hematology analyzers: An evaluation of the impact of preanalytical factors
Annika Åstrand, Cecilia Wingren, Claire Walton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 21, 2020
Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors
Bonnie S Glisson, Rom S Leidner, Robert L Ferris, et al.
Cytometry. Part B, Clinical Cytometry
|
December 29, 2020
Best practices for the development, analytical validation and clinical implementation of flow cytometric methods for chimeric antigen receptor T cell analyses
Ghanashyam Sarikonda, Mélissa Mathieu, Mahwish Natalia, et al.
Cytometry. Part B, Clinical Cytometry
|
August 21, 2024
Flow cytometry assay modifications: Recommendations for method validation based on CLSI H62 guidelines
Sara A Monaghan, Steven Eck, Silvia Bunting, et al.
Cancer Research Communications
|
September 3, 2025
IPH5201, an anti-CD39 monoclonal antibody, as monotherapy or in combination with durvalumab in advanced solid tumors
John Powderly, Martina Imbimbo, Antoine Italiano, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Current Protocols in Cytometry
|
November 13, 2018
Flow Cytometry Method Validation Protocols
Nithianandan Selliah, Steven Eck, Cherie Green, et al.
Cellular Immunology
|
May 5, 2009
Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD)
Tinghua Cao, Allis Soto, Wei Zhou, et al.
Current Protocols
|
January 25, 2024
Correction: Flow Cytometry Method Validation Protocols
Nithianandan Selliah, Veronica Nash, Steven Eck, et al.
Current Protocols
|
August 22, 2023
Flow Cytometry Method Validation Protocols
Nithianandan Selliah, Veronica Nash, Steven Eck, et al.
Cytometry. Part B, Clinical Cytometry
|
September 17, 2020
High-sensitivity flow cytometric assays: Considerations for design control and analytical validation for identification of Rare events
Ulrike Sommer, Steven Eck, Laura Marszalek, et al.
Plos One
|
May 24, 2024
A comparative study of blood cell count in four automated hematology analyzers: An evaluation of the impact of preanalytical factors
Annika Åstrand, Cecilia Wingren, Claire Walton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 21, 2020
Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors
Bonnie S Glisson, Rom S Leidner, Robert L Ferris, et al.
Cytometry. Part B, Clinical Cytometry
|
December 29, 2020
Best practices for the development, analytical validation and clinical implementation of flow cytometric methods for chimeric antigen receptor T cell analyses
Ghanashyam Sarikonda, Mélissa Mathieu, Mahwish Natalia, et al.
Cytometry. Part B, Clinical Cytometry
|
August 21, 2024
Flow cytometry assay modifications: Recommendations for method validation based on CLSI H62 guidelines
Sara A Monaghan, Steven Eck, Silvia Bunting, et al.
Cancer Research Communications
|
September 3, 2025
IPH5201, an anti-CD39 monoclonal antibody, as monotherapy or in combination with durvalumab in advanced solid tumors
John Powderly, Martina Imbimbo, Antoine Italiano, et al.
Page
of 3